Literature DB >> 26869347

The genetic background of Parkinson's disease: current progress and future prospects.

K Kalinderi1, S Bostantjopoulou2, L Fidani3.   

Abstract

Almost two decades of genetic research in Parkinson's disease (PD) have remarkably increased our knowledge regarding the genetic basis of PD with numerous genes and genetic loci having been found to cause familial PD or affect the risk for PD. Approximately 5-10% of PD patients have monogenic forms of the disease, exhibiting a classical Mendelian type of inheritance, however, the majority PD cases are sporadic, probably caused by a combination of genetic and environmental risk factors. Nowadays, six genes, alpha synuclein, LRRK2, VPS35, Parkin, PINK1 and DJ-1, have definitely been associated with an autosomal dominant or recessive PD mode of inheritance. The advent of genome-wide association studies (GWAS) and the implementation of new technologies, like next generation sequencing (NGS) and exome sequencing has undoubtedly greatly aided the identification on novel risk variants for sporadic PD. In this review, we will summarize the current progress and future prospects in the field of PD genetics.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  GBA; gene; lysosomes; parkinson's disease; pathway; risk factor

Mesh:

Year:  2016        PMID: 26869347     DOI: 10.1111/ane.12563

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  78 in total

1.  Arm swing as a potential new prodromal marker of Parkinson's disease.

Authors:  Anat Mirelman; Hagar Bernad-Elazari; Avner Thaler; Eytan Giladi-Yacobi; Tanya Gurevich; Mali Gana-Weisz; Rachel Saunders-Pullman; Deborah Raymond; Nancy Doan; Susan B Bressman; Karen S Marder; Roy N Alcalay; Ashwini K Rao; Daniela Berg; Kathrin Brockmann; Jan Aasly; Bjørg Johanne Waro; Eduardo Tolosa; Dolores Vilas; Claustre Pont-Sunyer; Avi Orr-Urtreger; Jeffrey M Hausdorff; Nir Giladi
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

Review 2.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

Review 3.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

4.  A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations.

Authors:  Shaghayegh Taghavi; Rita Chaouni; Abbas Tafakhori; Luis J Azcona; Saghar Ghasemi Firouzabadi; Mir Davood Omrani; Javad Jamshidi; Babak Emamalizadeh; Gholam Ali Shahidi; Mona Ahmadi; Seyed Amir Hassan Habibi; Azadeh Ahmadifard; Atena Fazeli; Marzieh Motallebi; Peyman Petramfar; Saeed Askarpour; Shiva Askarpour; Hossein Ali Shahmohammadibeni; Neda Shahmohammadibeni; Hajar Eftekhari; Amir Ehtesham Shafiei Zarneh; Saeed Mohammadihosseinabad; Mehdi Khorrami; Safa Najmi; Ahmad Chitsaz; Parasto Shokraeian; Hossein Ehsanbakhsh; Jalal Rezaeidian; Reza Ebrahimi Rad; Faranak Madadi; Monavvar Andarva; Elham Alehabib; Minoo Atakhorrami; Seyed Erfan Mortazavi; Zahra Azimzadeh; Mahdis Bayat; Amir Mohammad Besharati; Mohammad Ali Harati-Ghavi; Samareh Omidvari; Zahra Dehghani-Tafti; Faraz Mohammadi; Banafsheh Mohammad Hossein Pour; Hamid Noorollahi Moghaddam; Ehsan Esmaili Shandiz; Arman Habibi; Zahra Taherian-Esfahani; Hossein Darvish; Coro Paisán-Ruiz
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

5.  Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson's Disease.

Authors:  Lamei Yuan; Zhi Song; Xiong Deng; Zhijian Yang; Yan Yang; Yi Guo; Hongwei Lu; Hao Deng
Journal:  Neurosci Bull       Date:  2017-03-24       Impact factor: 5.203

6.  Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.

Authors:  Shay Ben-Shachar; Zaid Afawi; Rafik Masalha; Samih Badarny; Tova Neiman; Dina Pavzner; Anat Bar-Shira; Avi Orr-Urtreger
Journal:  J Mol Neurosci       Date:  2017-09-15       Impact factor: 3.444

Review 7.  Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson's Disease: Therapeutic Rationale and Current Status.

Authors:  Tara Swart; Michael J Hurley
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

8.  SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease.

Authors:  Morgan Sturgeon; Perry Wu; Robert Cornell
Journal:  J Neurol Neuromedicine       Date:  2016-12-30

9.  Parkinson's Disease: Patients' Knowledge, Attitudes, and Interest in Genetic Counseling.

Authors:  Kristin A Maloney; Dina S Alaeddin; Rainer von Coelln; Shannan Dixon; Lisa M Shulman; Katrina Schrader; Yue Guan
Journal:  J Genet Couns       Date:  2018-03-02       Impact factor: 2.537

Review 10.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.